| scholarly article | Q13442814 |
| P50 | author | Jonas Cicenas | Q56797782 |
| Vaidotas Stankevicius | Q85647345 | ||
| Kestutis Suziedelis | Q87885624 | ||
| P2093 | author name string | Ryte Rynkeviciene | |
| Jurgita Usinskiene | |||
| Edita Miseikyte Kaubriene | |||
| Egle Strainiene | |||
| Ingrida Meskinyte | |||
| Julija Simiene | |||
| P2860 | cites work | Initial sequencing and analysis of the human genome | Q21045365 |
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes | Q24606352 | ||
| miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression | Q24610377 | ||
| The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway | Q49165446 | ||
| Long non-coding RNA HOTAIR enhances angiogenesis by induction of VEGFA expression in glioma cells and transmission to endothelial cells via glioma cell derived-extracellular vesicles | Q49262445 | ||
| MiR-19 regulates the proliferation and invasion of glioma by RUNX3 via β-catenin/Tcf-4 signaling | Q50017399 | ||
| Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression | Q50023947 | ||
| A novel circular RNA, hsa_circ_0046701, promotes carcinogenesis by increasing the expression of miR-142-3p target ITGB8 in glioma | Q50033868 | ||
| SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR-153. | Q50095018 | ||
| Long non-coding RNA H19 promotes proliferation and invasion in human glioma cells by downregulating miR-152. | Q50109077 | ||
| Long non-coding RNA HOTTIP promotes hypoxia-induced epithelial-mesenchymal transition of malignant glioma by regulating the miR-101/ZEB1 axis | Q50196672 | ||
| Biology and clinical relevance of noncoding sno/scaRNAs | Q50226251 | ||
| MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5. | Q50294965 | ||
| miR-152 regulated glioma cell proliferation and apoptosis via Runx2 mediated by DNMT1. | Q50594880 | ||
| Silencing of lncRNA-CCDC26 Restrains the Growth and Migration of Glioma Cells In Vitro and In Vivo Via Targeting miR-203. | Q52091875 | ||
| PIWIL1/piRNA-DQ593109 Regulates the Permeability of the Blood-Tumor Barrier via the MEG3/miR-330-5p/RUNX3 Axis. | Q52369044 | ||
| Promotional effect of microRNA-194 on breast cancer cells via targeting F-box/WD repeat-containing protein 7. | Q52655150 | ||
| PVT1 regulates the malignant behaviors of human glioma cells by targeting miR-190a-5p and miR-488-3p. | Q52675738 | ||
| The implication and potential applications of high-mobility group box 1 protein in breast cancer | Q26744069 | ||
| Crosstalk between Long Noncoding RNAs and MicroRNAs in Health and Disease | Q26765464 | ||
| Circulating glioma biomarkers | Q26830329 | ||
| Integrative modelling of the influence of MAPK network on cancer cell fate decision | Q28534949 | ||
| MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3 | Q28564217 | ||
| Long noncoding RNAs: functional surprises from the RNA world | Q29615826 | ||
| Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis. | Q30252747 | ||
| PIWI proteins are essential for early Drosophila embryogenesis | Q30571062 | ||
| Radiotherapy and sequential temozolomide compared with radiotherapy with concomitant and sequential temozolomide in the treatment of newly diagnosed glioblastoma multiforme | Q33372474 | ||
| SNORD76, a box C/D snoRNA, acts as a tumor suppressor in glioblastoma | Q33559570 | ||
| MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression | Q33618467 | ||
| Long non-coding RNA XIST exerts oncogenic functions in human glioma by targeting miR-137. | Q33623161 | ||
| MicroRNAs as biomarkers associated with bladder cancer | Q33642335 | ||
| Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6 | Q33648713 | ||
| Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship | Q33719798 | ||
| Long Noncoding RNAs as Biomarkers in Cancer | Q33786847 | ||
| Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness | Q33911224 | ||
| MiR-181b sensitizes glioma cells to teniposide by targeting MDM2. | Q34136136 | ||
| Piwil2 suppresses p53 by inducing phosphorylation of signal transducer and activator of transcription 3 in tumor cells | Q34150088 | ||
| Functional interactions among microRNAs and long noncoding RNAs | Q34175339 | ||
| CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186. | Q34487797 | ||
| Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor. | Q34504777 | ||
| Survival and death strategies in glioma cells: autophagy, senescence and apoptosis triggered by a single type of temozolomide-induced DNA damage | Q34576873 | ||
| MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1) | Q34837779 | ||
| MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells | Q34842477 | ||
| Targeting the SMO oncogene by miR-326 inhibits glioma biological behaviors and stemness | Q34886908 | ||
| Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s) | Q34972742 | ||
| Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia | Q34978154 | ||
| Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells | Q35025350 | ||
| Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner | Q35238513 | ||
| An Lnc RNA (GAS5)/SnoRNA-derived piRNA induces activation of TRAIL gene by site-specifically recruiting MLL/COMPASS-like complexes | Q35476467 | ||
| MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells | Q35604297 | ||
| A specific miRNA signature in the peripheral blood of glioblastoma patients | Q45256953 | ||
| Evaluation of miR-711 as Novel Biomarker in Prostate Cancer Progression | Q47096115 | ||
| Long Non-coding RNA XIST Promotes Glioma Tumorigenicity and Angiogenesis by Acting as a Molecular Sponge of miR-429. | Q47099833 | ||
| The role of miRNA and lncRNA in gastric cancer | Q47117573 | ||
| The biology and mathematical modelling of glioma invasion: a review | Q47124238 | ||
| Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122. | Q47129437 | ||
| Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial | Q47232913 | ||
| lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients | Q47262117 | ||
| MiR-21 enhanced glioma cells resistance to carmustine via decreasing Spry2 expression | Q47306950 | ||
| Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma | Q47733432 | ||
| Long non-coding RNA PVT1 indicates a poor prognosis of glioma and promotes cell proliferation and invasion via target EZH2. | Q47766271 | ||
| Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis | Q47807782 | ||
| MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway. | Q47826034 | ||
| MicroRNA203a suppresses glioma tumorigenesis through an ATM-dependent interferon response pathway. | Q47852882 | ||
| Long Noncoding RNA HOXA11-AS Functions as miRNA Sponge to Promote the Glioma Tumorigenesis Through Targeting miR-140-5p | Q47918071 | ||
| Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status | Q48009750 | ||
| Long noncoding RNA PCAT1 regulates extrahepatic cholangiocarcinoma progression via the Wnt/β-catenin-signaling pathway | Q48016921 | ||
| Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells | Q48097769 | ||
| Down-regulation of the long noncoding RNA-HOX transcript antisense intergenic RNA inhibits the occurrence and progression of glioma. | Q48133028 | ||
| Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study | Q48157598 | ||
| Genome-wide small noncoding RNA profiling of pediatric high-grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII-52 and delineates H3F3A and TP53 mutant-specific miRNAs and snoRNAs | Q48167948 | ||
| lncRNA CCAT1 Promotes Glioma Tumorigenesis by Sponging miR-181b. | Q48185500 | ||
| miR-155 contributes to the progression of glioma by enhancing Wnt/β-catenin pathway | Q48334053 | ||
| A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma | Q48348576 | ||
| Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. | Q48380068 | ||
| MicroRNA-181b Inhibits Cellular Proliferation and Invasion of Glioma Cells via Targeting Sal-Like Protein 4. | Q48400278 | ||
| Expression of long non-coding RNA CRNDE in glioma and its correlation with tumor progression and patient survival | Q48462444 | ||
| Circulating microRNA-137 is a potential biomarker for human glioblastoma | Q48502936 | ||
| Long non-coding RNA TUG1 acts as a miR-26a sponge in human glioma cells | Q48647907 | ||
| LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway | Q48857932 | ||
| FGF-1-induced matrix metalloproteinase-9 expression in breast cancer cells is mediated by increased activities of NF-kappaB and activating protein-1. | Q38295975 | ||
| Tissue invasion and metastasis: Molecular, biological and clinical perspectives | Q38417443 | ||
| Malat1 activates autophagy and promotes cell proliferation by sponging miR-101 and upregulating STMN1, RAB5A and ATG4D expression in glioma | Q38611576 | ||
| LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair (MMR) pathway | Q38613368 | ||
| Circulating miRNAs as non-invasive biomarkers for non-small cell lung cancer diagnosis, prognosis and prediction of treatment response. | Q38632637 | ||
| Long non-coding RNA Fer-1-like family member 4 is overexpressed in human glioblastoma and regulates the tumorigenicity of glioma cells | Q38633650 | ||
| Long non-coding RNA expression profile in cervical cancer tissues | Q38633685 | ||
| Long noncoding RNA CASC2 predicts the prognosis of glioma patients and functions as a suppressor for gliomas by suppressing Wnt/β-catenin signaling pathway | Q38661397 | ||
| LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway | Q38664488 | ||
| Unique features of long non-coding RNA biogenesis and function | Q38668939 | ||
| miR-142 inhibits the migration and invasion of glioma by targeting Rac1. | Q38676340 | ||
| Upregulation of the long non-coding RNA SNHG1 predicts poor prognosis, promotes cell proliferation and invasion, and reduces apoptosis in glioma | Q38684236 | ||
| MiR-429 suppresses glioblastoma multiforme by targeting SOX2. | Q38696293 | ||
| Long Noncoding RNA CRNDE Promotes Proliferation of Gastric Cancer Cells by Targeting miR-145. | Q38704039 | ||
| Glioma cells promote angiogenesis through the release of exosomes containing long non-coding RNA POU3F3. | Q38710814 | ||
| Knockdown of linc-OIP5 inhibits proliferation and migration of glioma cells through down-regulation of YAP-NOTCH signaling pathway | Q38716783 | ||
| Long non-coding RNA ENST00462717 suppresses the proliferation, survival, and migration by inhibiting MDM2/MAPK pathway in glioma | Q38716800 | ||
| The lncRNA UCA1 interacts with miR-182 to modulate glioma proliferation and migration by targeting iASPP. | Q38718810 | ||
| Epithelial-mesenchymal transition in glioblastoma progression | Q38719842 | ||
| Long noncoding RNA FTX is upregulated in gliomas and promotes proliferation and invasion of glioma cells by negatively regulating miR-342-3p | Q38719974 | ||
| Long non-coding RNA ZFAS1 is an unfavourable prognostic factor and promotes glioma cell progression by activation of the Notch signaling pathway | Q38721697 | ||
| LncRNA H19 is overexpressed in glioma tissue, is negatively associated with patient survival, and promotes tumor growth through its derivative miR-675. | Q38725984 | ||
| Highly expressed lncRNA CCND2-AS1 promotes glioma cell proliferation through Wnt/β-catenin signaling | Q38727405 | ||
| Silencing of the long non-coding RNA NEAT1 suppresses glioma stem-like properties through modulation of the miR-107/CDK6 pathway | Q38729439 | ||
| Upregulation of Long Noncoding RNA Small Nucleolar RNA Host Gene 18 Promotes Radioresistance of Glioma by Repressing Semaphorin 5A. | Q38735765 | ||
| Knockdown of long noncoding RNA AB073614 inhibits glioma cell proliferation and migration via affecting epithelial-mesenchymal transition | Q38738008 | ||
| PVT1 affects growth of glioma microvascular endothelial cells by negatively regulating miR-186. | Q38738395 | ||
| The lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP. | Q38738408 | ||
| Long non-coding RNA CCAT1 promotes glioma cell proliferation via inhibiting microRNA-410. | Q38739279 | ||
| Long non-coding RNA H19 regulates glioma angiogenesis and the biological behavior of glioma-associated endothelial cells by inhibiting microRNA-29a | Q38750973 | ||
| LncRNA-TP53TG1 Participated in the Stress Response Under Glucose Deprivation in Glioma | Q38751485 | ||
| MicroRNA-140 represses glioma growth and metastasis by directly targeting ADAM9. | Q38753302 | ||
| Long noncoding RNA SPRY4-IT1 is a prognostic factor for poor overall survival and has an oncogenic role in glioma | Q38755606 | ||
| A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma | Q37286350 | ||
| Post-transcriptional processing generates a diversity of 5'-modified long and short RNAs | Q37286495 | ||
| Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches | Q37287987 | ||
| miR-101 inhibits glioma cell invasion via the downregulation of COX-2. | Q37288437 | ||
| Long Non-coding RNA TUSC7, a Target of miR-23b, Plays Tumor-Suppressing Roles in Human Gliomas | Q37314044 | ||
| Over-expression of the long non-coding RNA HOTTIP inhibits glioma cell growth by BRE. | Q37336665 | ||
| Down-regulation of long non-coding RNA FOXD3 antisense RNA 1 (FOXD3-AS1) inhibits cell proliferation, migration, and invasion in malignant glioma cells | Q37393397 | ||
| Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by suppressing miR-155 expression and activating FBXW7 function | Q37447899 | ||
| Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma | Q37518265 | ||
| High expression of long noncoding RNA HULC is a poor predictor of prognosis and regulates cell proliferation in glioma | Q37536364 | ||
| Circular RNAs in cancer: an emerging key player | Q37555860 | ||
| miR-29c contribute to glioma cells temozolomide sensitivity by targeting O6-methylguanine-DNA methyltransferases indirectely | Q37580383 | ||
| The multifaceted role of MTDH/AEG-1 in cancer progression | Q37590524 | ||
| The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients | Q37619766 | ||
| Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e | Q37641753 | ||
| TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1β/Derlin-1 pathway | Q37655453 | ||
| Silencing of cZNF292 circular RNA suppresses human glioma tube formation via the Wnt/β-catenin signaling pathway | Q37665353 | ||
| MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma | Q37694818 | ||
| Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells | Q37697223 | ||
| PPARα, a predictor of patient survival in glioma, inhibits cell growth through the E2F1/miR-19a feedback loop | Q37708993 | ||
| Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment. | Q37735605 | ||
| HILI destabilizes microtubules by suppressing phosphorylation and Gigaxonin-mediated degradation of TBCB. | Q37743194 | ||
| CASC2c as an unfavorable prognosis factor interacts with miR-101 to mediate astrocytoma tumorigenesis | Q37745367 | ||
| MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9. | Q37745975 | ||
| Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation | Q38058856 | ||
| RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis | Q38145091 | ||
| MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications | Q38174308 | ||
| MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells | Q35781470 | ||
| MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2 | Q35832262 | ||
| The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation | Q35846001 | ||
| miR-182 induces cervical cancer cell apoptosis through inhibiting the expression of DNMT3a. | Q35853954 | ||
| microRNA-182 inhibits the proliferation and migration of glioma cells through the induction of neuritin expression | Q35870231 | ||
| The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma | Q35967008 | ||
| Regulation of Cell Proliferation and Migration by miR-203 via GAS41/miR-10b Axis in Human Glioblastoma Cells. | Q36088612 | ||
| Long Noncoding RNA miR210HG as a Potential Biomarker for the Diagnosis of Glioma | Q36145810 | ||
| Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures | Q36268697 | ||
| Mechanisms of glioma-associated neovascularization | Q36295477 | ||
| A SnoRNA-derived piRNA interacts with human interleukin-4 pre-mRNA and induces its decay in nuclear exosomes | Q36337745 | ||
| PIWIL1 destabilizes microtubule by suppressing phosphorylation at Ser16 and RLIM-mediated degradation of Stathmin1. | Q36413910 | ||
| The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma. | Q36439245 | ||
| Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma | Q36560956 | ||
| Netrin-1 promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein | Q36561939 | ||
| Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells | Q36621362 | ||
| Potential Diagnostic and Prognostic Value of Plasma Circulating MicroRNA-182 in Human Glioma | Q36695308 | ||
| BRE plays an essential role in preventing replicative and DNA damage-induced premature senescence | Q36713665 | ||
| miR-21 Is Linked to Glioma Angiogenesis: A Co-Localization Study | Q36742601 | ||
| Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling | Q36774911 | ||
| Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma | Q36841827 | ||
| Angiogenesis in brain tumours | Q36887534 | ||
| MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas | Q36915053 | ||
| MiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma | Q36970349 | ||
| Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a | Q36976091 | ||
| HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas | Q37046635 | ||
| Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement | Q37061984 | ||
| The growing catalog of small RNAs and their association with distinct Argonaute/Piwi family members | Q37089444 | ||
| miR-148b-3p inhibits malignant biological behaviors of human glioma cells induced by high HOTAIR expression | Q37106829 | ||
| LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis | Q37107076 | ||
| MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells | Q37187706 | ||
| Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma | Q37190224 | ||
| miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis | Q37276897 | ||
| Tumor Microenvironment in Treatment of Glioma. | Q53101640 | ||
| Targeting MIR155HG in glioma: a novel approach. | Q53105313 | ||
| MicroRNA-associated carcinogenesis in lung carcinoma. | Q53177359 | ||
| MicroRNA-145 Regulates Neural Stem Cell Differentiation Through the Sox2-Lin28/let-7 Signaling Pathway. | Q53185606 | ||
| Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patients. | Q53210578 | ||
| Long Noncoding RNA UCA1 Targets miR-122 to Promote Proliferation, Migration, and Invasion of Glioma Cells. | Q53264572 | ||
| Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma. | Q53509559 | ||
| Long non-coding RNA MVIH acts as a prognostic marker in glioma and its role in cell migration and invasion. | Q55458789 | ||
| LncRNAs: macromolecules with big roles in neurobiology and neurological diseases. | Q38761452 | ||
| MDC1-AS, an antisense long noncoding RNA, regulates cell proliferation of glioma | Q38766589 | ||
| Silencing of Long Non-Coding RNA MALAT1 Promotes Apoptosis of Glioma Cells. | Q38773956 | ||
| CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis | Q38779789 | ||
| CRNDE Expression Positively Correlates with EGFR Activation and Modulates Glioma Cell Growth | Q38792627 | ||
| Knockdown of long non-coding RNA MALAT1 increases the blood-tumor barrier permeability by up-regulating miR-140. | Q38815741 | ||
| MicroRNA-140-5p inhibits cell proliferation and invasion by regulating VEGFA/MMP2 signaling in glioma | Q38819667 | ||
| miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics | Q38824458 | ||
| The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 | ||
| c-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma | Q38829331 | ||
| Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells | Q38843725 | ||
| miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met | Q38845681 | ||
| Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis | Q38846361 | ||
| Identification of IGF-1-enhanced cytokine expressions targeted by miR-181d in glioblastomas via an integrative miRNA/mRNA regulatory network analysis | Q38847110 | ||
| Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326. | Q38852126 | ||
| The long non-coding RNA TP73-AS1 interacted with miR-142 to modulate brain glioma growth through HMGB1/RAGE pathway. | Q38852993 | ||
| Upregulation of miR-107 Inhibits Glioma Angiogenesis and VEGF Expression | Q38862889 | ||
| The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144 | Q38863697 | ||
| MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2. | Q38879280 | ||
| The influence of SRPK1 on glioma apoptosis, metastasis, and angiogenesis through the PI3K/Akt signaling pathway under normoxia | Q38891990 | ||
| CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling | Q38894596 | ||
| Smad-independent TGF-β2 signaling pathways in human trabecular meshwork cells | Q38907178 | ||
| Differential expression of PDGFRB and EGFR in microvascular proliferation in glioblastoma | Q38910687 | ||
| Long Noncoding RNA MEG3 Suppresses Glioma Cell Proliferation, Migration, and Invasion By Acting As Competing Endogenous RNA of MiR-19a | Q38918954 | ||
| miR-155 Regulates Glioma Cells Invasion and Chemosensitivity by p38 Isforms In Vitro. | Q38925936 | ||
| Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21. | Q38935662 | ||
| Functional linc-POU3F3 is overexpressed and contributes to tumorigenesis in glioma | Q38935956 | ||
| Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016. | Q38949192 | ||
| Tight Junctions of the Blood-Brain Barrier - A Molecular Gatekeeper | Q38955653 | ||
| MiR-181a regulates blood-tumor barrier permeability by targeting Krüppel-like factor 6. | Q38960375 | ||
| Long non-coding RNA NEAT1 regulates permeability of the blood-tumor barrier via miR-181d-5p-mediated expression changes in ZO-1, occludin, and claudin-5. | Q38968021 | ||
| LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma | Q38974695 | ||
| MiR-122/Wnt/β-catenin regulatory circuitry sustains glioma progression | Q38991254 | ||
| A network-biology perspective of microRNA function and dysfunction in cancer | Q38994476 | ||
| A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells | Q38994539 | ||
| PI3K and Bcl-2 inhibition primes glioblastoma cells to apoptosis through downregulation of Mcl-1 and Phospho-BAD. | Q39001789 | ||
| The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression | Q39076309 | ||
| C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells | Q39076813 | ||
| TFAM is directly regulated by miR-23b in glioma | Q39100619 | ||
| Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4. | Q39133433 | ||
| Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1. | Q39158791 | ||
| MicroRNA-107 inhibits U87 glioma stem cells growth and invasion | Q39168771 | ||
| MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression | Q39214165 | ||
| Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer. | Q39293814 | ||
| MiR-410 regulates MET to influence the proliferation and invasion of glioma | Q39322020 | ||
| MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2. | Q39420627 | ||
| Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy | Q39640321 | ||
| IDH1 mutation-associated long non-coding RNA expression profile changes in glioma | Q40576605 | ||
| The Role of HOTAIR/miR-148b-3p/USF1 on Regulating the Permeability of BTB. | Q41024288 | ||
| High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer | Q41073179 | ||
| Analysis of long non-coding RNA expression profiles in ovarian cancer | Q41142365 | ||
| MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells | Q41161526 | ||
| Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion | Q41206487 | ||
| SNORD47, a box C/D snoRNA, suppresses tumorigenesis in glioblastoma | Q41279669 | ||
| Reciprocal regulation of miRNAs and piRNAs in embryonic development | Q41517632 | ||
| Decreased expression of microRNA-107 predicts poorer prognosis in glioma | Q41570375 | ||
| Identification of long non-coding RNAs biomarkers associated with progression of endometrial carcinoma and patient outcomes | Q41592814 | ||
| Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma | Q41593059 | ||
| Efficacy and safety of long-term therapy for high-grade glioma with temozolomide: A meta-analysis | Q41613008 | ||
| A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells | Q41906601 | ||
| H19 derived microRNA-675 regulates cell proliferation and migration through CDK6 in glioma | Q42239876 | ||
| MicroRNA‑21 promotes migration and invasion of glioma cells via activation of Sox2 and β‑catenin signaling. | Q42315668 | ||
| Serum microRNA profiling in patients with glioblastoma: a survival analysis | Q42317085 | ||
| Knockdown of long non-coding RNA XIST increases blood-tumor barrier permeability and inhibits glioma angiogenesis by targeting miR-137. | Q42339290 | ||
| MicroRNA-145 induces apoptosis of glioma cells by targeting BNIP3 and Notch signaling | Q42365280 | ||
| Long non-coding RNAs and prostate cancer | Q43061701 | ||
| Epidemiology of glial and non-glial brain tumours in Europe | Q44279365 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioma | Q1365309 |
| P304 | page(s) | 17 | |
| P577 | publication date | 2018-12-22 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | Non-Coding RNAs in Glioma | |
| P478 | volume | 11 |
| Q91012634 | Circulating biomarkers in patients with glioblastoma |
| Q89727163 | Functions and clinical significance of circular RNAs in glioma |
| Q90083971 | Homo Sapiens Circular RNA 0079993 (hsa_circ_0079993) of the POLR2J4 Gene Acts as an Oncogene in Colorectal Cancer Through the microRNA-203a-3p.1 and CREB1 Axis |
| Q92024293 | Hsa_circ_0002483 inhibited the progression and enhanced the Taxol sensitivity of non-small cell lung cancer by targeting miR-182-5p |
| Q98771978 | Immune-Related lncRNA Risk Signatures Predict Survival of IDH Wild-Type and MGMT Promoter Unmethylated Glioblastoma |
| Q91789619 | LINC00963 Confers Oncogenic Properties in Glioma by Regulating the miR-506/BCAT1 Axis |
| Q91715165 | Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges |
| Q90427414 | LncRNA RHPN1-AS1 Targeting miR-625/REG3A Promotes Cell Proliferation And Invasion Of Glioma Cells |
| Q92533723 | LncRNA SNHG5 Promotes Proliferation of Glioma by Regulating miR-205-5p/ZEB2 Axis |
| Q91828580 | Long Non-Coding RNA HOXA-AS2 Enhances The Malignant Biological Behaviors In Glioma By Epigenetically Regulating RND3 Expression |
| Q89883708 | Long Noncoding RNA SNHG6 Functions as an Oncogene in Non-Small Cell Lung Cancer via Modulating ETS1 Signaling |
| Q99630218 | Roles of long non-coding RNAs in the hallmarks of glioma |
| Q92665143 | Survival analysis of immune-related lncRNA in low-grade glioma |
| Q92795090 | The Role of Non-Coding RNA in Congenital Heart Diseases |
Search more.